106 related articles for article (PubMed ID: 25548895)
21. Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas.
Høgdall EV; Christensen L; Høgdall CK; Frederiksen K; Gayther S; Blaakaer J; Jacobs IJ; Kjaer SK
APMIS; 2008 May; 116(5):400-9. PubMed ID: 18452430
[TBL] [Abstract][Full Text] [Related]
22. miR-335 represents an independent prognostic marker in epithelial ovarian cancer.
Cao J; Cai J; Huang D; Han Q; Chen Y; Yang Q; Yang C; Kuang Y; Li D; Wang Z
Am J Clin Pathol; 2014 Mar; 141(3):437-42. PubMed ID: 24515774
[TBL] [Abstract][Full Text] [Related]
23. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
[TBL] [Abstract][Full Text] [Related]
24. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
[TBL] [Abstract][Full Text] [Related]
25. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
27. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer].
Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700
[TBL] [Abstract][Full Text] [Related]
28. Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer.
Leoutsakou T; Talieri M; Scorilas A
Biochem Biophys Res Commun; 2006 Jun; 344(2):667-74. PubMed ID: 16631123
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
30. Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma.
Kulkarni AA; Kingsbury SR; Tudzarova S; Hong HK; Loddo M; Rashid M; Rodriguez-Acebes S; Prevost AT; Ledermann JA; Stoeber K; Williams GH
Clin Cancer Res; 2009 Apr; 15(7):2417-25. PubMed ID: 19318489
[TBL] [Abstract][Full Text] [Related]
31. Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
Li YL; Ye F; Cheng XD; Hu Y; Zhou CY; Lü WG; Xie X
Eur J Cancer; 2010 Jul; 46(11):2104-18. PubMed ID: 20547056
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Growth-Related Oncogene-β Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer.
Ye Q; Zhai X; Wang W; Zhang S; Zhu H; Wang D; Wang C
Dis Markers; 2015; 2015():387382. PubMed ID: 26063953
[TBL] [Abstract][Full Text] [Related]
33. Highly sulfated chondroitin sulfates, a novel class of prognostic biomarkers in ovarian cancer tissue.
Vallen MJ; Massuger LF; ten Dam GB; Bulten J; van Kuppevelt TH
Gynecol Oncol; 2012 Oct; 127(1):202-9. PubMed ID: 22733095
[TBL] [Abstract][Full Text] [Related]
34. High levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancer.
Wang K; Li D; Sun L
Onco Targets Ther; 2016; 9():377-86. PubMed ID: 26855586
[TBL] [Abstract][Full Text] [Related]
35. KAP1 is a Novel Substrate for the Arginine Methyltransferase PRMT5.
di Caprio R; Ciano M; Montano G; Costanzo P; Cesaro E
Biology (Basel); 2015 Jan; 4(1):41-9. PubMed ID: 25585209
[TBL] [Abstract][Full Text] [Related]
36. Expression of KAP1 in epithelial ovarian cancer and its correlation with drug-resistance.
Hu M; Fu X; Cui Y; Xu S; Xu Y; Dong Q; Sun L
Int J Clin Exp Med; 2015; 8(10):17308-20. PubMed ID: 26770323
[TBL] [Abstract][Full Text] [Related]
37. A novel role of TRIM28 B box domain in L1 retrotransposition and ORF2p-mediated cDNA synthesis.
Du Q; Stow EC; LaCoste D; Freeman B; Baddoo M; Shareef AM; Miller KM; Belancio VP
Nucleic Acids Res; 2023 May; 51(9):4429-4450. PubMed ID: 37070200
[TBL] [Abstract][Full Text] [Related]
38. Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review.
Czerwinska P; Mackiewicz AA
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674511
[TBL] [Abstract][Full Text] [Related]
39. TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype.
Kim YS; Potashnikova DM; Gisina AM; Kholodenko IV; Kopylov AT; Tikhonova OV; Kurbatov LK; Saidova AA; Tvorogova AV; Kholodenko RV; Belousov PV; Vorobjev IA; Zgoda VG; Yarygin KN; Lupatov AY
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077272
[TBL] [Abstract][Full Text] [Related]
40. The Emerging Role of E3 Ubiquitin Ligase SMURF2 in the Regulation of Transcriptional Co-Repressor KAP1 in Untransformed and Cancer Cells and Tissues.
Shah PA; Boutros-Suleiman S; Emanuelli A; Paolini B; Levy-Cohen G; Blank M
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
